14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026
ABVX vs KALU: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 19, 2026, Kaiser Aluminum Corporation (KALU) is the stronger overall head-to-head candidate over Abivax SA (ABVX) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABVX carries a Unified Composite Score of 64.5/100 (BUY) at $80.65 (N/M Forward P/E, -6270.4% operating margin), whereas KALU carries 45.1/100 (HOLD) at $98.38 (27.7x Forward P/E, 7.6% operating margin).
Composite vs. Pillar Nuance: While ABVX currently prints a higher short-term Unified Composite Score (64.5/100 BUY vs. KALU 45.1/100 HOLD), KALU captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (7.6% vs. -6270.4% operating margin) and revenue trajectory (+44.0% vs. -6.8% YoY).
Technical & Structure Timing Caution: ABVX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.1); meanwhile KALU is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVX vs KALU. Trailing 12-month operating profitability (ABVX -6270.4% vs KALU 7.6%) and valuation multiples (ABVX N/M vs KALU 27.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Aluminum value chain with $1.6B market capitalization and 7.6% operating margin.
OpEx & R&D Reinvestment5.8% of Rev ($261M)
90D Engineering Disclosures0 Published
Investor FAQ ABVX vs KALU Key Questions & Quantitative Answers
As of Nov 19, 2026, Kaiser Aluminum Corporation (KALU) is the stronger overall head-to-head candidate over Abivax SA (ABVX) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABVX carries a Unified Composite Score of 64.5/100 (BUY) at $80.65 (N/M Forward P/E, -6270.4% operating margin), whereas KALU carries 45.1/100 (HOLD) at $98.38 (27.7x Forward P/E, 7.6% operating margin). Composite vs. Pillar Nuance: While ABVX currently prints a higher short-term Unified Composite Score (64.5/100 BUY vs. KALU 45.1/100 HOLD), KALU captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (7.6% vs. -6270.4% operating margin) and revenue trajectory (+44.0% vs. -6.8% YoY). Technical & Structure Timing Caution: ABVX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.1); meanwhile KALU is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
KALU leads the Growth & Scale pillar: ABVX posts -6.8% YoY revenue growth and +0.0% YoY earnings growth on $4.7M TTM revenue (100.0% gross margin, -6270.4% operating margin), compared with KALU at +44.0% YoY revenue growth and -22.7% YoY earnings growth on $4.51B TTM revenue (13.4% gross margin, 7.6% operating margin). On trailing 12-month operating scale, ABVX generates $4.7M in USD-normalized revenue versus $4.51B for KALU. In operating R&D and SG&A reinvestment, ABVX deploys N/A (0 90-day corporate R&D disclosures) versus 5.8% of Rev ($261M) (0 disclosures) for KALU.
KALU screens cheaper on headline valuation multiples. ABVX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported EBITDA margin), whereas KALU trades at 27.7x Forward P/E, 7.8x Trailing P/E, 1.17x PEG, and 0.4x EV/Revenue (10.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ABVX (-252.3% ROE) versus KALU (24.5% ROE) capital efficiency.
In options market volatility and institutional positioning, ABVX carries 76.9% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.46β · 44% Vol realized risk). By comparison, KALU carries 19.1% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.91β · 104% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.